NCT06457373 Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation
| NCT ID | NCT06457373 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Horus University |
| Condition | Alveolar Bone Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-08-13 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-08-13 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to evaluate and compare clinically and radiographically the effectiveness of Demineralized Dentin Allograft (DDA) versus Demineralized Dentin Autograft (Auto-DD) for preservation of alveolar ridge dimensions after surgical extraction of the impacted mandibular third molar.
Eligibility Criteria
Inclusion Criteria: 1. Patients aged between 25 to 35 years old. 2. Patients scored as (ASA I). 3. No adverse habits such as smoking, tobacco chewing, alcohol. 4. Patients having bilaterally impacted mandibular third molar with similar degree of difficulty according to (Kim JY, et al). 5. The recipient alveolar sockets are free of any pre-existing periapical pathology, based on x-ray. 6. Alveolar sockets with a depth of 5 mm or more, using periodontal probe for assessment. 7. Patients sign a consent for all procedures. Exclusion Criteria: * 1\) Pregnant or lactating patients. 2) Relevant systemic diseases. 3) Patients with history of chemotherapy or radiotherapy.
Contact & Investigator
Mohamed Habib, B.D.S
PRINCIPAL INVESTIGATOR
Faculty of Dentistry- Horus University in Egypt
Frequently Asked Questions
Who can join the NCT06457373 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 35 Years, studying Alveolar Bone Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06457373 currently recruiting?
Yes, NCT06457373 is actively recruiting participants. Contact the research team at mbasiouny@horus.edu.eg for enrollment information.
Where is the NCT06457373 trial being conducted?
This trial is being conducted at Damietta, Egypt.
Who is sponsoring the NCT06457373 clinical trial?
NCT06457373 is sponsored by Horus University. The principal investigator is Mohamed Habib, B.D.S at Faculty of Dentistry- Horus University in Egypt. The trial plans to enroll 40 participants.